CYB002

**CYB002** is an early Cybin psychedelic drug-development candidate in the company’s psilocybin program. Public disclosures identify it as one of Cybin’s proprietary psilocybin candidates alongside CYB001 and CYB003, but the company has not provided sufficient public detail to clearly establish a distinct non-code generic name, exact molecular design, dosage form, route, or validated mechanism beyond its association with psilocybin-based psychedelic therapeutics. Based on available company materials, it appears to have remained a preclinical or discovery-stage asset and has not emerged as an active late-stage development program. Because the publicly available information is sparse and largely limited to pipeline listings, key attributes should be treated as not specifically disclosed.